Adverse Reactions to Intravenous Immunoglobulins - Our Experience

Retinal vasculitis and uveitis--an adverse reaction to intravenous immunoglobulins?

Delayed adverse reactions to total-dose intravenous iron polymaltose.

The rate of infusion reactions to total-dose intravenous iron polymaltose is very low, but the frequency and severity of adverse reactions following the infusion are unknown. In 50 consecutive patients, adverse reactions developed up to 2 days after the infusion in 26% and lasted 1-8 days (median 4). Severe systemic reactions occurred in 8%. Patients should be warned of the chance of delayed re...

Intravenous immunoglobulins control scleromyxoedema.

BACKGROUND Scleromyxoedema is a variant of papular mucinosis affecting the skin and internal organs. The different therapeutic approaches proposed for scleromyxoedema are still unsatisfactory. Intravenous immunoglobulin (IVIg) has been successfully employed in the treatment of connective tissue diseases and vasculitides. PATIENTS The successful treatment of three cases of scleromyxoedema with...

Protecting Our Elderly Patients from Adverse Drug Reactions.

C JHP – Vol. 69, No. 4 – July–August 2016 JCPH – Vol. 69, no 4 – juillet–août 2016 of care (long-term care) who subsequently experienced an ADR. These results suggest that screening elderly patients for prescribing of inappropriate medications, as defined by the Beers criteria, would assist the pharmacist in triaging to ensure that those in most need receive attention. Other investigators have ...

Adverse reactions to radiopharmaceuticals.

This review covers the side effects and adverse reactions to radiopharmaceuticals that were reported in the literature over the past 25 years. The information published prior to 1970 is sporadic, but due to the increased utilization of nuclear medicine procedures and the recognition that radiopharmaceuticals may have pharmacologic side effects, a registry has existed since 1971 to tabulate info...